SERVICES
Clinical Communications & Media Strategy
Translate complex medical evidence into clear, credible communications that stand up to clinical, regulatory, medical affairs, and public scrutiny.
THE PROBLEM
Where healthcare innovations lose their footing
Healthcare companies often face a difficult communications problem: the science is complex, but the audience still needs to understand why it matters.
Oversimplify the message and scientific credibility is lost. Overstate what the evidence supports and the message becomes vulnerable to regulatory, medical, or commercial scrutiny. Make it too technical and clinicians, investors, patients, or the public may never understand the value.
RNB Ventures helps organizations translate the science without diluting it, creating communications that are scientifically accurate, clinically meaningful, audience-appropriate, and commercially useful.
WHAT'S INCLUDED
How the engagement helps
Clinical Narrative & Message Architecture
Translate clinical evidence into a coherent narrative that connects the science, clinical value, evidence, and intended audience.
Medical Affairs & HCP Communications
Develop credible physician education, KOL materials, clinical presentations, and evidence-based communications for healthcare professionals.
Scientific Publications & Congress
Support peer-reviewed manuscripts, abstracts, posters, presentations, white papers, clinical compendia, and conference strategy through our scientific communications capability.
Executive Communications & Media
Prepare executives and medical leaders for presentations, interviews, video, podcasts, investor communications, and public-facing media.
Keynote Speaking
Thought-provoking presentations for healthcare, medtech, investment, and innovation audiences.
Public, Patient & Digital
Translate complex clinical concepts into understandable print, visual, video, social-media, and patient-facing content without sacrificing scientific integrity.
Good Chemistry specifically brings publication lifecycle management, scientific conference strategy, and scientific materials for physicians, MSLs, payers, patients, sales teams, and investors.
WHY PHYSICIAN-LED
We interpret the science before we communicate it
We interpret the science before we communicate the science. Clinical communications should not begin with copywriting. It should begin by understanding what the evidence demonstrates, what it does not demonstrate, why the findings matter clinically, and what each audience needs to understand. RNB combines physician judgment, medical affairs experience, regulatory awareness, scientific communications, and media expertise so that different audiences may hear different emphasis, but encounter the same underlying truth.
THE TEAM
Who delivers this work
RNB Ventures works with selected specialists when an engagement requires expertise beyond Dr. Bilkovski's core medical and strategic advisory role. This model allows RNB to assemble the right expertise for the problem while maintaining senior-level oversight and accountability.
Robert N. Bilkovski, MD, MBA
Founder & Physician Strategist
Dr. Bilkovski brings more than two decades of experience across medical affairs, clinical development, regulatory strategy, commercialization, and executive medical leadership in medical devices, diagnostics, and pharmaceuticals. His prior medical leadership includes Abbott, GE Healthcare, and Hospira/Pfizer, and he has served as a Regulatory Affairs Professionals Society (RAPS) annual-meeting panelist addressing medtech advertising and promotion.
Joseph J. Pinzone, MD, MBA, FACP
Physician Communications & Media Advisor
Dr. Pinzone combines academic medicine, pharmaceutical medical affairs leadership, and extensive national media experience. His training includes NYU School of Medicine, Columbia-Presbyterian Medical Center, and Massachusetts General Hospital / Harvard Medical School, where he completed endocrinology training and NIH-funded research. He previously served as Head of Medical Affairs supporting XGEVA at Amgen and has hosted PBS programming and appeared as a national medical expert across television and digital media.
Eric J. Moorhead, MS
Good Chemistry Communications
Scientific Communications & Publications Partner
Eric Moorhead (Good Chemistry Communications) brings more than 10 years of scientific communications experience across pharmaceuticals, medical devices, biotechnology, and strategic consulting. His background includes scientific communications leadership at Avanos Medical, where he led medical strategy across a multi-product portfolio, authorship of more than 10 peer-reviewed manuscripts, and senior scientific consulting experience at Spectrum Science.
HOW WE WORK
A clear process
01
Evidence Review
Understand the clinical evidence, audience, intended claims, communication objective, and regulatory boundaries.
02
Message Architecture
Determine what the audience needs to understand, what the evidence supports, and how the scientific and clinical narrative should be structured.
03
Content Development & Delivery
Create the appropriate written, visual, publication, digital, or media deliverable and support executive or physician preparation where needed.
WHO IT'S FOR
Who this serves
Medical-device innovators preparing for launch and clinical adoption; diagnostics and IVD companies translating performance data into clinical value; biotechnology and pharmaceutical teams supporting medical education and commercialization; medical affairs and commercial leaders needing evidence-based communications; investor-backed healthcare companies preparing for financing, regulatory, partnership, or launch milestones; and executives and physician leaders preparing for media, investor, conference, or public-facing communications.
QUESTIONS
Frequently asked
How is RNB's approach different from a traditional healthcare communications or PR agency?
We begin with the medicine and evidence. Physician interpretation and scientific credibility come before creative execution. When specialized publication or media capabilities are required, we bring those disciplines into the engagement.
Can you make highly technical medical concepts understandable to patients or the general public?
Yes. The goal is to simplify the communication, not the science. We identify the essential clinical meaning and translate it into language appropriate for the audience without changing what the evidence actually supports.
Can you support advertising, promotion, and MLR review?
Yes. We can help assess whether clinical claims, comparative statements, risk balance, and promotional messages remain consistent with the supporting evidence and intended communication. Final regulatory or legal approval remains with the appropriate company functions.
Do you support manuscripts and scientific conferences?
Yes. Through Good Chemistry Communications, engagements can include manuscript development, journal strategy, abstracts, posters, scientific presentations, conference planning, KOL support, and related scientific materials.
Can you prepare executives or physicians for media appearances?
Yes. Dr. Pinzone and the RNB team can help refine the medical narrative, anticipate difficult questions, translate technical concepts for the intended audience, and prepare the spokesperson for broadcast, digital, podcast, investor, or other public-facing communications.